Why the study?
Current VTE treatment recommendations are based on previous studies, but they should be applied with careful consideration of racial, genetic, and social characteristics in the Korean population amid increasing VTE incidence in Asia.
Answers are grounded in this paper and cite their sources.
This guideline provides updated, Korea-specific clinical recommendations for the management of venous thromboembolism, reflecting the increasing use of direct oral anticoagulants.
Venous thromboembolism (VTE), which includes pulmonary embolism and deep vein thrombosis, is a condition characterized by abnormal blood clot formation in the pulmonary arteries and the deep venous vasculature. It is often serious and sometimes even fatal if not promptly and appropriately treated. Moreover, the later consequences of VTE may result in reduced quality of life. The treatment of VTE depends on various factors, including the type, cause, and patient comorbidities. Furthermore, bleeding may occur as a side effect of VTE treatment. Thus, it is necessary to carefully weigh the benefits versus the risks of VTE treatment and to actively monitor patients undergoing treatment. Asian populations are known to have lower VTE incidences than Western populations, but recent studies have shown an increase in the incidence of VTE in Asia. A variety of treatment options are currently available owing to the introduction of direct oral anticoagulants. The current VTE treatment recommendation is based on evidence from previous studies, but it should be applied with careful consideration of the racial, genetic, and social characteristics in the Korean population.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: